Apr 28, 2026 9 min read Regulation & Policy FDA Sets July 2026 PCAC Hearing for BPC-157, TB-500, MOTS-C, Semax, and More The FDA has published the agenda for its July 2324, 2026 Pharmacy Compounding Advisory Committee (P
Mounjaro can be injected at any time of the day, whatever works best for you
The combination of all four pathways should theoretically produce earlier onset of appetite suppression, more sustained fullness between meals, increased resting energy expenditure from the glucagon component, and a reduced tendency toward the metabolic adaptation that commonly causes weight loss plateaus on single-agent therapy
The lyophilized (freeze-dried) powder is extremely stable
Safety data from trials In a paper summarizing 6 randomized, double-blind, placebo-controlled human trials, AOD 9604 did not significantly affect IGF-1 levels, did not impair glucose tolerance, and no serious adverse events (SAEs) were attributed to AOD 9604
, 18 , 313-329, doi: Lu, S